Sachiko Kuno

Dr. Sachiko Kuno is a committed scientist, philanthropist, and entrepreneur whose mission is to empower others to change the world by providing the support needed to advance their innovative ideas. Currently she acts as President and CEO of S&R Evermay and serves on the Board of Directors for numerous organizations including DeNA and Monex Group, Inc. She also serves as Adjunct Professor at Kyoto University. Within her career, Dr. Kuno has launched Halcyon Incubator (which has three fellows in attendance tonight) and co-founded WE Capital, Phoenixi Co. Inc, R-Tech Ueno, Ltd. (Japan) Sucampo Pharmaceuticals (U.S.) (sold in 2018), and VLP Therapeutics (U.S).  She has also successfully developed and commercialized two pharmaceutical products.

Kuno has received a number of awards over the years, including the Ernst and Young Entrepreneur of the Year Award for the Greater Washington Area in the Life Sciences Category (2007) and recognition as one of the 25 “Women Who Mean Business” by The Washington Business Journal (2009). She has also been named in Forbes Magazine’s Top 50 America’s Richest Self Made Women (2015) and the World’s 100 Most Powerful Women by Forbes Japan (2015). She was most recently selected “Business Stateswoman of the Year” by the Harvard Business School Club of Japan (2016).